Monoclonal Antibody, Anti Ft LVS LpnA/Tu14 Clone 164

Background

Francisella tularensis is an intracellular, gram-negative bacterium that invades macrophages and initiates the human immune response.

Technology

Tularemia, commonly known as ?rabbit fever? can be communicated across several species including; rabbits, rodents and humans. The murine monoclonal antibody recognizes a native epitope of Francisella tularensis ?Live Vaccine Strain?; IgG monoclonal antibody clone 164 against a native epitope of Francisella tularensis protein, LpnA/Tu14.

Advantages

The antibody was developed from a mouse infected with F.tularensis live vaccine strain and not recombinant protein, therefore representing a natural antibody made by the mouse in defence of infection against the native F. tularensis protein.

Application

Western blot - ELISA - Immunoprecipitation - Immunofluorescence assays

Patent Status

Stage Of Development

Licensing Potential

Licensing

Licensing Status

Available for license.

Additional Info

Additional Information:

https://stonybrook.technologypublisher.com/files/sites/8098-monoclonal-antibody--anti-ft-lvs-lpna-tu14-clone-164.jpg Source: Gavin Allanwood, unsplash.com/photos/hcxqLJjI99E, Unsplash Licence